CONFORMA THERAPEUTICS
Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer. It develops drugs that induce tumor cells to degrade the proteins that promote cancer growth. The company offers HSP90 and CNF1010 which are used for the treatment of cancer. The company was incorporated in 1999 and is based in San Diego, California
CONFORMA THERAPEUTICS
Industry:
Health Care Therapeutics
Founded:
1999-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(858)657-0300
Total Funding:
30 M USD
Similar Organizations
Therinject
Therinject is a pharmaceutical company focused on developing therapeutics for the treatment of cancer.
Investors List
SR One
SR One investment in Series C - Conforma Therapeutics
Novo Holdings
Novo Holdings investment in Series C - Conforma Therapeutics
Inglewood Ventures
Inglewood Ventures investment in Series C - Conforma Therapeutics
Domain Associates
Domain Associates investment in Series C - Conforma Therapeutics
Lilly Ventures
Lilly Ventures investment in Series C - Conforma Therapeutics
ProQuest Investments
ProQuest Investments investment in Series C - Conforma Therapeutics
Forward Ventures
Forward Ventures investment in Series C - Conforma Therapeutics
RBC Capital Markets
RBC Capital Markets investment in Series C - Conforma Therapeutics
RiverVest
RiverVest investment in Series C - Conforma Therapeutics
More informations about "Conforma Therapeutics"
Conforma Therapeutics Company Profile 2024: …
The current revenue for Conforma Therapeutics is . How much funding has Conforma Therapeutics raised over time? Conforma Therapeutics has raised $66.3M. Who are Conforma Therapeutics’s investors? Domain Associates, …See details»
Conforma Therapeutics - Funding, Financials, Valuation & Investors
Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ...See details»
Conforma Therapeutics Corporation Company Profile, Financial …
Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer. It develops drugs that induce tumor cells to degrade the proteins that promote cancer growth. …See details»
Conforma Therapeutics Corp.: Drug pipelines, Patents, Clinical …
Explore Conforma Therapeutics Corp. with its drug pipeline, therapeutic area, technology platform, 17 literature, Drug:CNF-316 series, CNF-201 series.See details»
Biogen acquires Conforma Therapeutics - 2006-05-03 - Crunchbase
May 3, 2006 Conforma Therapeutics Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer. Acquiring Organization: Biogen Biogen is an American …See details»
Conforma Therapeutics Corporation - Rivervest
/ PORTFOLIO San Diego, CAConforma Therapeutics discovered and developed drugs that inhibit heat shock protein 90 (HSP90) molecules, which are involved in protecting and supporting the …See details»
CONFORMA THERAPEUTICS CORPORATION :: California (US) :: …
Jan 28, 2010 Free and open company data on California (US) company CONFORMA THERAPEUTICS CORPORATION (company number 2179882), 225 BINNEY ST. …See details»
Conforma Therapeutics Corp.:Company Profile & Technical …
Conforma Therapeutics Corp. is headquartered in United States California. Conforma Therapeutics Corp. was founded in 1999. Conforma Therapeutics Corp. has a total of 170 …See details»
Conforma Therapeutics - Products, Competitors, Financials, …
Conforma Therapeutics Completes Round of Private Financing to Support Clinical Development. Jun 19, 2013. BIOWIRE2K May 02, 2005 09:05 AM Eastern Daylight Time SAN DIEGO--( …See details»
Home - Conforma
Conforma is a GMP and ISO 13485 certified pharmaceutical and medical device company specializing in producing and packaging semi-solids and liquids. Our state-of-the-art facility, equipped with advanced technology and equipment, …See details»
Conforma Therapeutics Corp. - VentureRadar
Similar Companies: QAtor Denmark Privately Held QAtor is a global software firm specialising in compliance and Quality Assurance software for the Life Sciences Industry. The company has …See details»
Biogen Idec to Acquire Conforma Therapeutics
May 3, 2006 Cambridge, MA - Biogen Idec and Conforma Therapeutics Corporation, a privately held biopharmaceutical company focused on the design and development of novel drugs for …See details»
Conforma Therapeutics - Crunchbase
Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer.See details»
Conforma Therapeutics Corp - Company Profile and News
Company profile page for Conforma Therapeutics Corp including stock price, company news, executives, board members, and contact informationSee details»
Biogen Idec to buy Conforma for $250M - Fierce Biotech
May 2, 2006 Biogen Idec is paying $150 million up front to buy Conforma Therapeutics and will pay up to $100 million more based on the success of Conforma's pipeline of cancer therapies. …See details»
Biogen Idec, Inc. (Massachusetts) To Expand Oncology ... - BioSpace
May 3, 2006 CAMBRIDGE, Mass. & SAN DIEGO--(BUSINESS WIRE)--May 3, 2006--Biogen Idec (NASDAQ: BIIB - News) and Conforma Therapeutics Corporation, a privately held …See details»
Biogen Idec expands oncology pipeline, acquires Conforma …
Jun 29, 2006 CAMBRIDGE, Mass.—In a move that will expand its oncology pipeline, and perhaps its neurological and immunological discovery efforts, Biogen Idec announced in early …See details»
Conforma Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Conforma Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit …See details»
Biogen in up to $250M bid for Conforma
May 14, 2006 US drugmaker Biogen Idec has entered into a definitive merger agreement with privately-held biopharmaceutical firm Conforma Therapeutics, based in San Diego, USA, …See details»
CytoMed Therapeutics signs Business & Research Collaboration …
4 hours ago CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf …See details»